| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2016PLoSO..1156771S |
| P356 | DOI | 10.1371/JOURNAL.PONE.0156771 |
| P932 | PMC publication ID | 4902218 |
| P698 | PubMed publication ID | 27285311 |
| P50 | author | Chiara Baglioni | Q91561285 |
| Kai Spiegelhalder | Q92468944 | ||
| Wolfram Regen | Q114445958 | ||
| Dieter Riemann | Q25506806 | ||
| Bernd Feige | Q45293145 | ||
| Christoph Nissen | Q46727254 | ||
| P2093 | author name string | Thomas Lange | |
| Jürgen Hennig | |||
| P2860 | cites work | Unedited in vivo detection and quantification of γ-aminobutyric acid in the occipital cortex using short-TE MRS at 3 T. | Q50708449 |
| Efficient γ-aminobutyric acid editing at 3T without macromolecule contamination: MEGA-SPECIAL | Q60644502 | ||
| Estimation of metabolite concentrations from localized in vivo proton NMR spectra | Q72319396 | ||
| Why Most Discovered True Associations Are Inflated | Q24273233 | ||
| Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits | Q24538295 | ||
| Effectiveness of non-benzodiazepine hypnotics in treatment of adult insomnia: meta-analysis of data submitted to the Food and Drug Administration | Q24633044 | ||
| A self-assessment questionnaire to determine morningness-eveningness in human circadian rhythms | Q28143399 | ||
| A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale | Q28256570 | ||
| The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research | Q29547257 | ||
| Power failure: why small sample size undermines the reliability of neuroscience | Q29547474 | ||
| Hypothalamic regulation of sleep and circadian rhythms | Q29619151 | ||
| Three-dimensional magnetization-prepared rapid gradient-echo imaging (3D MP RAGE). | Q30456733 | ||
| Cramér-Rao bounds: an evaluation tool for quantitation | Q30654307 | ||
| Simultaneous in vivo spectral editing and water suppression | Q31982014 | ||
| Neuroimaging insights into insomnia | Q33360071 | ||
| Reduced brain GABA in primary insomnia: preliminary data from 4T proton magnetic resonance spectroscopy (1H-MRS). | Q33384845 | ||
| In vivo quantification of intracerebral GABA by single-voxel (1)H-MRS-How reproducible are the results? | Q33406732 | ||
| Diurnal stability of gamma-aminobutyric acid concentration in visual and sensorimotor cortex | Q33520275 | ||
| The relationship between brain morphology and polysomnography in healthy good sleepers | Q34282902 | ||
| Insomnia and risk of cardiovascular disease: a meta-analysis | Q34401455 | ||
| Reduced γ-aminobutyric acid in occipital and anterior cingulate cortices in primary insomnia: a link to major depressive disorder? | Q35892779 | ||
| The role of GABA in primary insomnia | Q35962668 | ||
| Cortical GABA levels in primary insomnia | Q35962689 | ||
| Insomnia disorder is associated with increased amygdala reactivity to insomnia-related stimuli | Q35993658 | ||
| Measuring T2 in vivo with J-difference editing: application to GABA at 3 Tesla | Q36041495 | ||
| Reproducibility and effect of tissue composition on cerebellar γ-aminobutyric acid (GABA) MRS in an elderly population | Q36126016 | ||
| Dysfunctional beliefs and attitudes about sleep (DBAS): validation of a brief version (DBAS-16) | Q36151517 | ||
| Measuring the longitudinal relaxation time of GABA in vivo at 3 Tesla. | Q36492271 | ||
| Insomnia does not appear to be associated with substantial structural brain changes | Q36761299 | ||
| Insomnia with objective short sleep duration: the most biologically severe phenotype of the disorder. | Q36901887 | ||
| Nighttime blood pressure in normotensive subjects with chronic insomnia: implications for cardiovascular risk. | Q37212644 | ||
| Objective sleep disturbances are associated with greater waking resting-state connectivity between the retrosplenial cortex/ hippocampus and various nodes of the default mode network | Q37227026 | ||
| T2 measurement of J-coupled metabolites in the human brain at 3T | Q37367243 | ||
| The hyperarousal model of insomnia: a review of the concept and its evidence | Q37501210 | ||
| National use of prescription medications for insomnia: NHANES 1999-2010. | Q37510465 | ||
| Insomnia and health-related quality of life | Q37644964 | ||
| Cortical gamma-aminobutyric acid and glutamate in posttraumatic stress disorder and their relationships to self-reported sleep quality | Q37700406 | ||
| Societal costs of insomnia | Q37723060 | ||
| Insomnia as a predictor of depression: a meta-analytic evaluation of longitudinal epidemiological studies | Q37837216 | ||
| The occupational impact of sleep quality and insomnia symptoms | Q37991829 | ||
| Comorbid sleep disorders in neuropsychiatric disorders across the life cycle. | Q38103504 | ||
| The neurobiology, investigation, and treatment of chronic insomnia. | Q38431654 | ||
| Towards a valid, reliable measure of sleep effort | Q40364059 | ||
| Epidemiology of insomnia: what we know and what we still need to learn | Q40610246 | ||
| Proton T (1) and T (2) relaxation times of human brain metabolites at 3 Tesla | Q43690929 | ||
| Insomnia and the risk of acute myocardial infarction: a population study | Q44170280 | ||
| Insomnia and daytime cognitive performance: a meta-analysis | Q46115579 | ||
| Insomnia disorder | Q46788076 | ||
| Reduced anterior internal capsule white matter integrity in primary insomnia | Q48092424 | ||
| Insomnia and the risk of incident heart failure: a population study | Q48190430 | ||
| The associations of insomnia with costly workplace accidents and errors: results from the America Insomnia Survey | Q48220059 | ||
| Heart rate and heart rate variability in subjectively reported insomnia | Q48349509 | ||
| Prefrontal GABA concentration changes in women-Influence of menstrual cycle phase, hormonal contraceptive use, and correlation with premenstrual symptoms. | Q48421907 | ||
| Validation of the Insomnia Severity Index as an outcome measure for insomnia research | Q48689674 | ||
| Long-term reproducibility of GABA magnetic resonance spectroscopy | Q48755555 | ||
| Automatic quantitation of localized in vivo 1H spectra with LCModel | Q48842365 | ||
| The phenomenology of the pre-sleep state: the development of the pre-sleep arousal scale | Q49052633 | ||
| Macromolecule contamination in GABA editing using MEGA-PRESS should be properly accounted for. | Q49075551 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e0156771 | |
| P577 | publication date | 2016-06-10 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Magnetic Resonance Spectroscopy in Patients with Insomnia: A Repeated Measurement Study | |
| P478 | volume | 11 |
| Q55441858 | Abnormal Functional Connectivity of Anterior Cingulate Cortex in Patients With Primary Insomnia: A Resting-State Functional Magnetic Resonance Imaging Study. |
| Q53405576 | Altered ultradian cortisol rhythmicity as a potential neurobiologic substrate for chronic insomnia. |
| Q47680091 | An Objective Short Sleep Insomnia Disorder Subtype Is Associated With Reduced Brain Metabolite Concentrations In Vivo: A Preliminary Magnetic Resonance Spectroscopy Assessment |
| Q92018312 | Cerebral Metabolites on the Descending Limb of Acute Alcohol: A Preliminary 1H MRS Study |
| Q38679739 | Clinical Sleep-Wake Disorders II: Focus on Insomnia and Circadian Rhythm Sleep Disorders. |
| Q40163637 | Genome-wide association analysis of insomnia complaints identifies risk genes and genetic overlap with psychiatric and metabolic traits. |
| Q99618089 | Insomnia with objective short sleep duration is associated with cognitive impairment: a first look at cardiometabolic contributors to brain health |
| Q92955610 | Metabolism of sleep and aging: Bridging the gap using metabolomics |
| Q47819498 | The Molecular Basis of Insomnia: Implication for Therapeutic Approaches |
Search more.